BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business Update
April 17, 2023 16:25 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, April 17, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing...